23 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Powerful Proof Anyone Can Invest for an Early Retirement - April 17, 2020 http://www.zacks.com/stock/news/875973/powerful-proof-anyone-can-invest-for-an-early-retirement-april-17-2020?cid=CS-ZC-FT-retirement_ideas|secrets_to_an_early_retirement-875973 Apr 17, 2020 - Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments, it can be achievable.
Top Stock Reports for Microsoft, Walmart & Amgen http://www.zacks.com/research-daily/872353/top-stock-reports-for-microsoft-walmart-amgen?cid=CS-ZC-FT-research_daily-872353 Apr 15, 2020 - Top Stock Reports for Microsoft, Walmart & Amgen
4 GARP Stocks to Scoop Up for Maximum Returns http://www.zacks.com/stock/news/872211/4-garp-stocks-to-scoop-up-for-maximum-returns?cid=CS-ZC-FT-analyst_blog|rw-872211 Apr 15, 2020 - If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
6 Recession-Proof Picks Amid Coronavirus-Led "The Great Lockdown" http://www.zacks.com/stock/news/872034/6-recession-proof-picks-amid-coronavirus-led-the-great-lockdown?cid=CS-ZC-FT-analyst_blog|investment_ideas-872034 Apr 15, 2020 - Coronavirus outbreak-induced global lockdowns are making recession inevitable. Here are six recession-resistant stocks including Netflix (NFLX) to beat COVID-19 induced recession woes.
Pharma Stocks Rally on Sanofi, GSK Coronavirus Vaccine Tie-Up http://www.zacks.com/stock/news/871951/pharma-stocks-rally-on-sanofi-gsk-coronavirus-vaccine-tie-up?cid=CS-ZC-FT-analyst_blog|industry_focus-871951 Apr 15, 2020 - If successful, the Sanofi (SNY) and GlaxoSmithKline plc (GSK) vaccine would be available in the second half of 2021. Shares of drugmakers jumped on the news.
Will J&J's Pharma Unit Perform Above Market to Drive Q1 Result? http://www.zacks.com/stock/news/868906/will-jjs-pharma-unit-perform-above-market-to-drive-q1-result?cid=CS-ZC-FT-analyst_blog|earnings_preview-868906 Apr 13, 2020 - J&J's (JNJ) Pharma segment is delivering an above-market performance despite currency headwinds and the impact of biosimilar and generic competition.
Merck's Keytruda Gets FDA's Priority Review for Solid Tumors http://www.zacks.com/stock/news/861111/mercks-keytruda-gets-fdas-priority-review-for-solid-tumors?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-861111 Apr 08, 2020 - Merck's (MRK) sBLA seeking approval of Keytruda for advanced solid tumors, based on biomarker, regardless of tumor type, gets FDA's priority review.
Biotech Stock Roundup: AMGN & INCY Focus on Coronavirus Treatments, & More http://www.zacks.com/stock/news/860777/biotech-stock-roundup-amgn-incy-focus-on-coronavirus-treatments-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-860777 Apr 08, 2020 - The biotech sector is in focus with pipeline updates from companies evaluating treatments for the novel COVID-19.
Biotech Stocks, ETFs to Gain on COVID-19 Vaccine & Drug Progress http://www.zacks.com/stock/news/859545/biotech-stocks-etfs-to-gain-on-covid-19-vaccine-drug-progress?cid=CS-ZC-FT-etf_news_and_commentary-859545 Apr 07, 2020 - The race to introduce a vaccine and drug for COVID-19 is creating near-term opportunities, making the biotech sector a lucrative space for investments.
Regeneron-Sanofi's Dupixent Data Positive in Atopic Dermatitis http://www.zacks.com/stock/news/857351/regeneron-sanofis-dupixent-data-positive-in-atopic-dermatitis?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-857351 Apr 06, 2020 - Regeneron (REGN) and Sanofi announce positive detailed data on Dupixent in children aged 6-11 years with uncontrolled severe atopic dermatitis.

Pages: 123

<Page 2